Non-invasive diagnosis of urinary bladder cancer

Non-invasive diagnosis of urothelial carcinoma with urinary biomarkers and imaging after macroscopic haematuria

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN17940603

Enrollment

2000

Registered

2020-09-04

Start date

2020-09-09

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnostic workup in patients with macroscopic haematuria Cancer Urothelial carcinoma, macroscopic haematuria

Interventions

Patients undergoing diagnostic workup according to a standardised care pathway for macroscopic haematuria will leave urine sample prior to cystoscopy. For the participants where cystoscopy detects a s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged =50 years 2. Referred to participating centres for evaluation of macroscopic haematuria according to standardised care pathway 3. Able to give signed informed consent

Exclusion criteria

Exclusion criteria: 1. History of urothelial carcinoma 2. Unable to give voided urine sample/has urine catheter

Design outcomes

Primary

Measure	Time frame
Diagnosis of urinary bladder cancer within one year of enrolment collected retrospectively from medical records at 1 year after enrolment	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026